A novel Caenorhabditis elegans allele, smn-1(cb131), mimicking a mild form of spinal muscular atrophy, provides a convenient drug screening platform highlighting new and pre-approved compounds
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A novel Caenorhabditis elegans allele, smn-1(cb131), mimicking a mild form of spinal muscular atrophy, provides a convenient drug screening platform highlighting new and pre-approved compounds
Authors
Keywords
-
Journal
HUMAN MOLECULAR GENETICS
Volume 20, Issue 2, Pages 245-260
Publisher
Oxford University Press (OUP)
Online
2010-10-21
DOI
10.1093/hmg/ddq459
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- SAHA ameliorates the SMA phenotype in two mouse models for spinal muscular atrophy
- (2010) Markus Riessland et al. HUMAN MOLECULAR GENETICS
- Altered Intracellular Ca2+ Homeostasis in Nerve Terminals of Severe Spinal Muscular Atrophy Mice
- (2010) R. Ruiz et al. JOURNAL OF NEUROSCIENCE
- GM1 ganglioside in Parkinson's disease: Results of a five year open study
- (2010) Jay S. Schneider et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- SMA CARNI-VAL Trial Part I: Double-Blind, Randomized, Placebo-Controlled Trial of L-Carnitine and Valproic Acid in Spinal Muscular Atrophy
- (2010) Kathryn J. Swoboda et al. PLoS One
- Conserved Genes Act as Modifiers of Invertebrate SMN Loss of Function Defects
- (2010) Maria Dimitriadi et al. PLoS Genetics
- Fast, automated measurement of nematode swimming (thrashing) without morphometry
- (2009) Steven D Buckingham et al. BMC NEUROSCIENCE
- Management of myasthenic conditions: nonimmune issues
- (2009) Zohar Argov CURRENT OPINION IN NEUROLOGY
- Sialic acids as regulators of molecular and cellular interactions
- (2009) Roland Schauer CURRENT OPINION IN STRUCTURAL BIOLOGY
- An in vitro screening cascade to identify neuroprotective antioxidants in ALS
- (2009) Siân C. Barber et al. FREE RADICAL BIOLOGY AND MEDICINE
- Evaluation of the therapeutic potential of carbonic anhydrase inhibitors in two animal models of dystrophin deficient muscular dystrophy
- (2009) J. Giacomotto et al. HUMAN MOLECULAR GENETICS
- Impaired Synaptic Vesicle Release and Immaturity of Neuromuscular Junctions in Spinal Muscular Atrophy Mice
- (2009) L. Kong et al. JOURNAL OF NEUROSCIENCE
- Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial
- (2009) Andrew D Goodman et al. LANCET
- Spinal muscular atrophy: why do low levels of survival motor neuron protein make motor neurons sick?
- (2009) Arthur H. M. Burghes et al. NATURE REVIEWS NEUROSCIENCE
- Valproic acid blocks excitability in SMA type I mouse motor neurons
- (2009) Kristen Rak et al. NEUROBIOLOGY OF DISEASE
- Deletion of smn-1, the Caenorhabditis elegans ortholog of the spinal muscular atrophy gene, results in locomotor dysfunction and reduced lifespan
- (2008) M. Briese et al. HUMAN MOLECULAR GENETICS
- Strategies for automated analysis of C. elegans locomotion
- (2008) Steven D. Buckingham et al. INVERTEBRATE NEUROSCIENCE
- The effect of hydroxyurea in spinal muscular atrophy cells and patients
- (2008) Wen-Chen Liang et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Dose comparison trial of sustained-release fampridine in multiple sclerosis
- (2008) A. D. Goodman et al. NEUROLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started